No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 7,804 | 11,201 | 11,235 | 9,612 | 10,792 | 13,134 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 345 | 796 | -70 | 88 | 135 | 182 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Zanyu Technology Group Co., Ltd., along with its affiliated entities, operates globally in the research, development, manufacturing, and distribution of surfactants and oleochemicals. The company boasts a comprehensive product range that includes key chemical compounds such as stearic acid glycol ester, disodium laureth sulfosuccinate, fatty acid methyl ester sulfonic acid, alkylbenzene sulfonic acid, and sodium linear alpha olefin sulfonate. Its offerings also encompass sodium and ammonium lauryl sulfates, their respective ether sulfates, and various betaines like cocamidopropyl and dodecyl dimethyl betaine. Furthermore, Zanyu supplies coco fatty diethanol amide, cocofatty acid monoethanol amide, specialized synthetic leather fatliquoring agents, sulphonated oils (SHO and SS), condensed phospholipin, POE fatty acid monoethanol amide ether, leather degreasing agents, and guar hydroxy propyl dimethyl, among other products. Beyond its core chemical operations, the group provides independent third-party testing services, focusing on areas such as food safety, environmental analysis, and occupational health. Founded in 1965, Zanyu Technology Group Co., Ltd. is headquartered in Hangzhou, China. The company adopted its current name in November 2016, having previously been known as Zhejiang Zanyu Technology Co., Ltd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Zanyu Technology Group Co., Ltd. (002637.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Zanyu Technology Group Co., Ltd., along with its affiliated entities, operates globally in the research, development, manufacturing, and distribution of surfactants and oleochemicals. The company boasts a comprehensive product range that includes key chemical compounds such as stearic acid glycol ester, disodium laureth sulfosuccinate, fatty acid methyl ester sulfonic acid, alkylbenzene sulfonic acid, and sodium linear alpha olefin sulfonate. Its offerings also encompass sodium and ammonium lauryl sulfates, their respective ether sulfates, and various betaines like cocamidopropyl and dodecyl dimethyl betaine. Furthermore, Zanyu supplies coco fatty diethanol amide, cocofatty acid monoethanol amide, specialized synthetic leather fatliquoring agents, sulphonated oils (SHO and SS), condensed phospholipin, POE fatty acid monoethanol amide ether, leather degreasing agents, and guar hydroxy propyl dimethyl, among other products. Beyond its core chemical operations, the group provides independent third-party testing services, focusing on areas such as food safety, environmental analysis, and occupational health. Founded in 1965, Zanyu Technology Group Co., Ltd. is headquartered in Hangzhou, China. The company adopted its current name in November 2016, having previously been known as Zhejiang Zanyu Technology Co., Ltd.